Carcinoembryonic antigen (CEA) is a well-established biomarker primarily associated with colorectal cancer, although it may also be elevated in other malignancies such as pancreatic, gastric, and lung cancers. This evidence concerns the gene CEACAM5 and lung carcinoma.